Timeline on the pandemic (H1N1) 2009
This timeline of the 2009 Influenza Pandemic runs from the first described cases in California in April 2009 to July 10th 2010 when the WHO Director General declared that the pandemic was over. It describes events from the perspective of European Union and European Economic Area institutions and countries. However it also contains global events of relevance to Europe, such as declarations of phase changes. Where possible, links are given to primary published documentation. Events, decisions and meetings taking place at a European Level are especially emphasised.
25-Mar-09: Onset of first cases in California of what turned out to be A(H1N1)
04-Apr-09: Outbreak of influenza like illness starts in Veracruz
15-Apr-09: First cases of severe disease noted in Mexico City
15-Apr-09: Novel influenza A(H1N1) identified and isolated in USA
17-Apr-09: Mexican authorities contact Canada requesting help with specimens
21-Apr-09: Mexican specimens arrive in National Microbiological Laboratory in Canada
21-Apr-09: Two swine influenza cases reported in California
24-Apr-09: ECDC goes to Public Health Event (PHE) level 1
24-Apr-09: First ECDC Threat Assessment finished
24-Apr-09: IHR Event Information Site posting confirming an outbreak of severe respiratory disease in Mexico caused by the novel influenza A (H1N1) virus
25-Apr-09: Publication of first ECDC Situation Report
25-Apr-09: 18 confirmed cases in Mexico (including 6 deaths)
25-Apr-09: WHO declares the novel influenza A (H1N1) outbreak in Mexico and US
26-Apr-09: Press briefing by Dr Fukuda: Containment is impossible
27-Apr-09: ECDC goes to PHE level 2
27-Apr-09: First cases reported in Europe: UK - 2 cases
27-Apr-09: European Commission press briefing on “swine flu” threat to Europe
27-Apr-09: First general Q & A published by ECDC
27-Apr-09: First confirmed cases reported in the EU (Spain and UK)
27-Apr-09: Declaration of Phase 4 by WHO and second meeting of the Emergency Committee
28-Apr-09: ECDC Press conference: Analysis and update on A(H1N1) and ECDC‟s assessment of the risk to public health
29-Apr-09: Declaration of Phase 5 by WHO
29-Apr-09: EMA says antiviral medicines are available in EU
29-Apr-09: EMA has a meeting with vaccine manufacturers
29-Apr-09: EU Commissioner for Health meets the association of European Vaccine Manufacturers to discuss the development and production of pandemic vaccines
30-Apr-09: Publication of first ECDC Risk Assessment
30-Apr-09: EMA prepares for approval of pandemic vaccines
30-Apr-09: EU agreement on Common Case Definition for new pandemic infection
30-Apr-09: Extraordinary EU Council of Health Ministers
30-Apr-09: ECDC publishes first Pandemic Risk Assessments
01-May-09: ECDC‟s announces press briefings to be held on working days at 16:00 CEST
01-May-09: EU agreement on common case definition for new pandemic infection
02-May-09: WHO publishes instructions on how to obtain PCR kits from United States CDC
03-May-09: First cases of in country transmission in Germany, Spain and UK
04-May-09: WHO statement on the H1N1 influenza situation
05-May-09: ECDC Webcasts on Influenza A(H1N1) to be held twice a week
05-May-09: The Directors of DG SANCO C (Public Health and Risk Assessment) and DG ENTR F (Consumer Goods and EU Satellite navigation programmes) inform ECDC and EMA that the Commission would like to set up a SANCO/ENTR/ECDC/EMA ad-hoc task force on vaccine development and vaccination strategies and ask ECDC and EMA to nominate members for the task force
05-May-09: WHO technical consultation to assess knowledge of severity of disease caused by influenza A(H1N1) and its implications
06-May-09: WHO technical consultation on the severity of disease caused by the new influenza A (H1N1) virus infections
06-May-09: EU Task Force on pandemic H1N1 influenza vaccine development and vaccination strategies holds its first audio conference
07-May-09: Joint FAO/WHO/OIE Statement on influenza A(H1N1) and the safety of pork
07-May-09: The EU Vaccine Task Force holds an audio conference with US Health Services (HHS, FDA, CDC, NIH) to exchange information on pandemic H1N1 influenza vaccine development
08-May-09: ECDC goes from PHE level 2 to PHE level 1
08-May-09: First update of ECDC‟s Risk Assessment
08-May-09: Publication by WHO of expected timelines for availability of candidate viruses for vaccine production by reverse genetics, classical reassortment and whole virus distribution
08-May-09 WHO - World is better prepared for influenza pandemic
08-May-09 EMA publishes recommendations on extension of shelf life for Tamiflu
08-May-09 EMA publishes its guidance on use of antiviral medicines in the event of an influenza A/H1N1 pandemic
08-May-09 WHO expected timelines for availability of candidate viruses for vaccine production by reverse genetics, classical re-assortment and whole virus distribution
12-May-09 ECDC broadcast on public health measures
15-May-09 WHO: Sharing of influenza viruses, access to vaccines and other benefits
18-May-09 High level consultation before and at the World Health Assembly including request for some delay in declaring Phase 6 by some Member States
18-May-09 WHO: Concern over flu pandemic justified
18-May-09 WHO: Pandemic threat deserves attention from all
19-May-09 Recommendation by WHO-SAGE on pandemic vaccines
19-May-09 ECDC guidance on personal health measures to reduce risk of influenza transmission
20-May-09 Second update of ECDC‟s Risk Assessment
20-May-09 Note on 'Vaccine production and vaccination strategies on influenza A (H1N1) in the European Union'
26-May-09 Characteristics of the emergent influenza A (H1N1) viruses and recommendations for vaccine development
26-May-09 WHO: Characteristics of the emergent influenza A (H1N1) viruses and recommendations for vaccine development (Endorsed by EMA on June 4th)
28-May-09 CDC Guidance on Antiviral Treatment of patients with confirmed, probable or suspected case of new Influenza A(H1N1)
29-May-09 Follow-up recommendations on use of antiviral medicines in the event of an influenza A/H1N1 pandemic
03-Jun-09 EMA announces extension of shelf-life for Relenza (Zanamivir)
04-Jun-09 EU recommendation for the emergent novel H1N1 influenza vaccine composition
04-Jun-09 Note of the ad-hoc task force on vaccine strategy and vaccine development (vaccination strategies and regulatory aspects)
05-Jun-09 Third meeting of WHO IHR Emergency Committee
06-Jun-09 ECDC Guidance on containment and mitigation
08-Jun-09 Written information from the Commission services on vaccines and vaccination against influenza A (H1N1): update as of 02 June 2009
08-Jun-09 EU Council of Health Ministers
09-Jun-09 European Commission workshop on animal – human interface aspects of the pandemic
11-Jun-09 Fourth meeting of IHR Emergency Committee
11-Jun-09 Declaration of Phase 6 by WHO
11-Jun-09 ECDC agrees with WHO‟s announcement of raising pandemic alert level to phase 6
11-Jun-09 World now at the start of 2009 influenza pandemic - Declaration of pandemic
11-Jun-09 EMA revised EU recommendation for composition of influenza vaccine
12-Jun-09 Third update of ECDC‟s Risk Assessment
12-Jun-09 EMA launches pandemic management plan
12-Jun-09 EMA in ongoing discussions with vaccine manufacturers
12-Jun-09 EMA launches pandemic management plan
15-Jun-09 First death in Europe reported from UK
17-Jun-09 WHO welcomes Sanofi-Aventis's donation of vaccine
18-Jun-09 Publication of PPT on evolution of the pandemic (H1N1) 2009
20-Jun-09 Publication of guidance on school closures by ECDC and article in Lancet
24-Jun-09 ECDC Press briefing on the Latest updates on pandemic (H1N1) 2009 and response strategies (mitigation versus containment)
24-Jun-09 ILI took off in UK (spring-summer wave)
01-Jul-09 UK moves from containment to mitigation of pandemic influenza
01-Jul-09 First fatal case in Spain
01-Jul-09 Publication of Threat Assessment - First isolation of a secondary oseltamivir-resistant A(H1N1)v strain in Denmark is published
02-Jul-09 „Influenza preparedness and response – lessons learned and next steps‟ /Jonkoping
02-Jul-09 EU Swedish Presidency meeting with experts from MS
02-Jul-09 WHO: Lessons learned and preparedness
02-Jul-09 EU Swedish Presidency technical meeting on the pandemic
03-Jul-09 „Coffee and the Commission‟: „Is the EU ready for the influenza pandemic?‟
06-Jul-09 Standard paediatric investigation plan adopted for pandemic-influenza vaccines
06-Jul-09 Dr. Isaac Weisfuse presentation on the outbreak of influenza A(H1N1)v in New York City
07-Jul-09 Written information from the Commission services on vaccines and vaccination against influenza A (H1N1)v: update as of 01
07-Jul-09 Informal Council meeting agrees on the unsustainability of containment strategies
08-Jul-09 WHO says there is no evidence indicating the development of widespread antiviral resistance among pandemic influenza A(H1N1)v
08-Jul-09 EMA published revised recommendations for pharmacovigilance plans for pandemic-influenza vaccines
09-Jul-09 Publication of clinical patient care checklist
13-Jul-09 Publication of first Executive Update for ECDC‟s key stakeholders
13-Jul-09 WHO recommendations on pandemic (H1N1) 2009 vaccines
14-Jul-09 Meeting convened by ECDC with Member States and WHO to devise a new EU pandemic surveillance strategy
14-Jul-09 ILI took off in Spain (spring-summer wave)
20-Jul-09 Fourth update of ECDC’s Risk Assessment
22-Jul-09 First fatal case Hungary
23-Jul-09 Publication of note by ECDC on school closures supporting Lancet article
23-Jul-09 Publication of the report "Europe‟s initial experience with pandemic (H1N1) 2009 - mitigation and delaying "policies and practices
24-Jul-09 Publication of report on priority groups for receipt of pandemic vaccines - SAGE
24-Jul-09 EMA publishes press release European Medicines Agency review of pandemic vaccines underway
26-Jul-09 CDC announced no longer reporting of number of cases
28-Jul-09 EMA says Relenza will be distributed with Rotacap/Rotahaler inhalation device during influenza pandemic
29-Jul-09 First ECDC/EPIET informal seminar on influenza pandemic investigations
30-Jul-09 ACIP meeting recommendations on US priority groups for pandemic influenza vaccine
30-Jul-09 First fatal case Belgium
30-Jul-09 First fatal case France
31-Jul-09 EMA recommends updating the product information for Tamiflu
04-Aug-09 First fatal case Netherlands
05-Aug-09 Briefing note on safety of pandemic vaccine by WHO
06-Aug-09 WHO briefing note on pandemic vaccines
07-Aug-09 First fatal case Ireland
10-Aug-09 ECDC Daily Situation Report changed format and name to Daily Update
13-Aug-09 Publication of Surveillance and studies in a pandemic: Report on fourth meeting of the SSiaP working group
13-Aug-09 Public Health agency of Canada published interim guidance for cruise ships
13-Aug-09 ECDC interim guidance: Use of specific pandemic influenza vaccines during the H1N1 2009 pandemic
13-Aug-09 Health Security Committee statement on School Closures and Travel Advice
13-Aug-09 Health Security Committee / Early Warning and Response System statement on School Closures
13-Aug-09 Health Security Committee / Early Warning and Response System statement on Travel Advice
14-Aug-09 UK publishes the pandemic vaccination priority groups
14-Aug-09 Switzerland publishes vaccination priority groups
17-Aug-09 WHO EURO workshop on deployment of pandemic (H1N1) 2009 vaccine
17-Aug-09 Call to action from WHO, IFRC, UNSIC, OCHA and UNICEF
18-Aug-09 ECDC updates its guidance on use of antivirals in a pandemic
18-Aug-09 First fatal case Malta
19-Aug-09 Regulatory process for the authorisation of antiviral medicines and vaccines in the protection against Pandemic Influenza (H1N1) 2009
19-Aug-09 Vaccination strategies against pandemic (H1N1) 2009
20-Aug-09 WHO issues a revision of its guidance on pharmacological management
21-Aug-09 Recommendations of the Advisory Committee on Immunization Practices (ACIP) on the use of influenza A(H1N1) 2009 monovalent vaccine
21-Aug-09 Fifth update of ECDC‟s Risk Assessment
21-Aug-09 Background note on Novel Influenza Vaccines: Authorisation, Access, Production, Vaccination Strategies
22-Aug-00 WHO recommendations on the use of antivirals
23-Aug-09 First fatal case Greece
24-Aug-09 US president‟s advisors release report assessing pandemic influenza preparedness
25-Aug-09 WHO regional meeting on response to the pandemic
25-Aug-09 International meeting in China concerning influenza, especially the pandemic
25-Aug-09 Recommendation from Health Security Committee on Vaccine Risk and Target Groups
26-Aug-09 ILI took off in Germany (autumn - winter wave)
29-Aug-09 Contribution to Health Security Committee / Early Warning and Response System Statement on Influenza A(H1N1) 2009: target and priority groups for vaccination
31-Aug-09 Publication of European Commission policy statement on vaccination target and priority groups
31-Aug-09 ECDC Executive Update is published on the web for a wider audience
02-Sep-09 First fatal case Sweden
03-Sep-09 Answers to a list of questions from the HSC extended section on Influenza Preparedness and Response
04-Sep-09 ECDC Director speaks to European Parliament's ENVI Committee
06-Sep-09 First fatal case Norway
14-Sep-09 Updating of ECDC guidance on public health measures for this pandemic
15-Sep-09 First fatal case Italy
15-Sep-09 59th session of the Regional Committee of the WHO European Region meeting
15-Sep-09 Publication of Overview of surveillance of influenza 2009/2010 in the EU/EEA
15-Sep-09 Publication of first Weekly Influenza Surveillance Overview
15-Sep-09 Meeting on vaccine safety project (VAESCO II)
15-Sep-09 Methodology for SCCS and CCS was discussed and established. Study protocol finalized
15-Sep-09 Methodology for investigating background rates for the selected AESIs was shared
15-Sep-09 External participants in meeting: EMA Jim Slattery
17-Sep-09 ILI took off in UK (autumn-winter wave)
17-Sep-09 Publication by ECDC of pandemic surveillance strategy
18-Sep-09 Meeting on Development of a pandemic vaccine risk-benefit assessment model
19-Sep-09 First fatal case Luxembourg
19-Sep-09 Pandemic vaccine donations for the developing world
22-Sep-09 Adoption by European Commission of a Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on Pandemic (H1N1)2009
22-Sep-09 Friends of the Presidency Group meeting
22-Sep-09 US, CDC and ECDC joint video conference to discuss the Pandemic H1N1 2009
22-Sep-09 Advisory Forum meeting
23-Sep-09 Special issue of Health EU newsletter on Pandemic (H1N1)
24-Sep-09 Oman begins vaccination
24-Sep-09 China begins vaccination
24-Sep-09 First fatal case Portugal
24-Sep-09 Positive scientific opinion CHMP/EMA on Docetria and Pandemrix, first two pandemic vaccines
25-Sep-09 Positive scientific opinion CHMP/EMA for two pandemic vaccines on September 24th
25-Sep-09 Support for developing countries‟ response to the H1N1 influenza pandemic
25-Sep-09 Statement following the fifth meeting of the Emergency Committee
25-Sep-09 Sixth update of ECDC‟s Risk Assessment
25-Sep-09 Addition of the pandemic strain recommended for the 2010 Southern Hemisphere season
25-Sep-09 EMA gives positive recommendations for authorisation of pandemic-influenza vaccines Focetria and Pandemrix
28-Sep-09 Scientific Committee‟s vaccine working party
28-Sep-09 Australia begins vaccination
28-Sep-09 Hungary begins vaccination
29-Sep-09 Authorization of first two pandemic vaccines by European Commission
30-Sep-09 First fatal case Bulgaria
30-Sep-09 First fatal case Germany
30-Sep-09 Authorization of first two pandemic vaccines (Focetria & Pandemrix) by European Commission
30-Sep-09 European Commission approves Focetria and Pandemrix for use in the H1N1 influenza pandemic
30-Sep-09 The EU Commissioner for Health and the EMA Director give an update on their activities at the Committee on the Environment, Public Health and Food Safety of the European Parliament
30-Sep-09 First use of pandemic Vaccine in Europe (Hungary)
01-Oct-09 Regular meeting of the EU Chief Medical Officers
01-Oct-09 European Medicines Agency recommends updating Tamiflu product information
01-Oct-09 European Strategy for Influenza A/H1N1 Vaccine Benefit-Risk Monitoring
01-Oct-09 Inventory of EU research activities and data sources related to the H1N1 vaccines B/R monitoring
02-Oct-09 European Medicines Agency recommends authorisation of Celvapan for use against pandemic influenza
05-Oct-09 Four pandemic influenza A(H1N1) 2009 vaccines available on the European market
05-Oct-09 US begins vaccination
05-Oct-09 ILI took off in Netherlands
06-Oct-09 Authorisation of third pandemic vaccine by the European Commission following positive scientific opinion CHMP/EMA on October 1st
08-Oct-09 Microsoft launches a web-based pandemic influenza self-assessment tool
12-Oct-09 Belgium begins vaccination
12-Oct-09 Sweden begins vaccination
12-Oct-09 Italy begins vaccination
12-Oct-09 EU Health Minister‟s Extraordinary Council meeting
12-Oct-09 „Strengthening Europe‟s Defences against Communicable Diseases‟ - Competent Bodies meeting
12-Oct-09 European Commission approves Celvapan for use in H1N1 pandemic
12-Oct-09 Extraordinary EU Council of Health Ministers
14-Oct-09 WHO meeting on Clinical Aspects of influenza (H1N1)2009
15-Oct-09 World Health Congress
15-Oct-09 Advisory Forum teleconference
15-Oct-09 ECDC article in Eurosurveillance on pandemic vaccines - Johansen et al
19-Oct-09 Pandemic influenza preparedness meeting on sharing of influenza viruses and access to vaccines and other benefits
19-Oct-09 First fatal case Iceland
20-Oct-09 Norway begins vaccination
20-Oct-09 France begins vaccination
20-Oct-09 Japan begins vaccination
20-Oct-09 Monaco begins vaccination
20-Oct-09 Finland begins vaccination
20-Oct-09 ILI took off in Italy
20-Oct-09 ILI took off in Spain (autumn-winter wave)
20-Oct-09 ILI took off in Bulgaria
20-Oct-09 ILI took off in Germany (autumn-winter wave)
22-Oct-09 UK begins vaccination
23-Oct-09 EMA scientific committee recommends updating product information for Focetria and Pandemrix
24-Oct-09 EMA maintains recommendation of two doses for pandemic vaccine
26-Oct-09 ESCAIDE 2009
26-Oct-09 Death of 13 year child in Toronto area (Canada) leads to dramatic change in attitude to immunisation
26-Oct-09 First fatal case Czech Republic
26-Oct-09 First fatal case Finland
28-Oct-09 Friends of the Presidency Group meeting
29-Oct-09 Slovenia begins vaccination
29-Oct-09 Austria begins vaccination
29-Oct-09 Canada begins vaccination
29-Oct-09 Germany begins vaccination
29-Oct-09 Kuwait begins vaccination
29-Oct-09 Luxembourg begins vaccination
29-Oct-0 Portugal begins vaccination
29-Oct-09 Republic of Korea begins vaccination
29-Oct-09 ILI took off in Denmark
29-Oct-09 ILI took off in Estonia
29-Oct-09 ILI took off in Sweden
30-Oct-09 Conference „Influenza at the interface between humans and animals‟
30-Oct-09 WHO SAGE Committee advises on pandemic vaccines
02-Nov-09 First fatal case Austria
05-Nov-09 Publication of European Strategy for Influenza A/H1N1Vaccine Benefit-Risk Monitoring
05-Nov-09 ECDC Management Board Meeting received briefing
05-Nov-09 European strategy for benefit-risk monitoring of influenza A/H1N1 vaccines adopted
05-Nov-09 European benefit-risk strategy published by EMA, ECDC and Heads of the European Medicines Agency
06-Nov-09 Seventh update of ECDC‟s Risk Assessment
06-Nov-09 Pandemic H1N1 outbreak in Ukraine
08-Nov-09 Denmark begins vaccination
08-Nov-09 Ireland begins vaccination
08-Nov-09 Israel begins vaccination
08-Nov-09 Qatar begins vaccination
08-Nov-09 Saudi Arabia begins vaccination
08-Nov-09 Singapore begins vaccination
08-Nov-09 Turkey begins vaccination
08-Nov-09 ILI took off in Austria
09-Nov-09 Delegation from the Ministry of Health in Turkey visits ECDC
09-Nov-09 First fatal case Latvia
09-Nov-09 First Q & A on vaccines for experts published
10-Nov-09 UAE begins vaccination
10-Nov-09 Switzerland begins vaccination
10-Nov-09 Russia begins vaccination
10-Nov-09 Netherlands begins vaccination
10-Nov-09 Spain begins vaccination
10-Nov-09 Agreement for donation of pandemic H1N1 vaccine signed
10-Nov-09 ILI took off in Lithuania
10-Nov-09 First Q & A on vaccines for general public published
11-Nov-09 Weekly global pharmacovigilance teleconference convened by WHO starts
12-Nov-09 Keynote lecture Influenza pandemic in the EU: the threat is real!
12-Nov-09 Meeting on pandemic influenza (H1N1) vaccination
12-Nov-09 Public Health Committee meeting
12-Nov-09 Health Security Committee meeting
12-Nov-09 CDC Estimates of 2009 H1N1 Influenza Cases, Hospitalizations and Deaths in the United States first published, April – October 17, 2009
15-Nov-09 First fatal case Poland
15-Nov-09 First weekly meeting of the EMA PREG group to review difficult AEFIs
16-Nov-09 Committee for Medicinal Products for Human Use (CHMP) meeting
16-Nov-09 Advisory Forum teleconference
16-Nov-09 ECDC's visit to Bulgaria
17-Nov-09 WHO meeting in Geneva
18-Nov-09 First fatal case Lithuania
18-Nov-09 Jordan begins vaccination
18-Nov-09 Greece begins vaccination
19-Nov-09 WHO Pandemic (H1N1) 2009 briefing note 16 on Safety of pandemic vaccines
20-Nov-09 ECDC‟s Visit to Turkey
20-Nov-09 First fatal case Denmark
20-Nov-09 EMA reaffirms efficacy and safety of H1N1v pandemic vaccines
23-Nov-09 First fatal case Romania
24-Nov-09 Friends of the Presidency Group meeting
24-Nov-09 First fatal case Slovenia
25-Nov-09 First fatal case Estonia
25-Nov-09 Romania begins vaccination
25-Nov-09 Cyprus begins vaccination
25-Nov-09 Croatia begins vaccination
26-Nov-09 Statement following the sixth meeting of the Emergency Committee
30-Nov-09 Vaccine Working Party
01-Dec-09 EU Council of Health Ministers
01-Dec-09 Contribution to EMA data on cumulative exposure data regarding H1N1 vaccines
01-Dec-09 Contribution to EMA discussions on composition of influenza vaccines for season 2010/2011
02-Dec-09 ECDC Director updated EU health ministers on influenza pandemic
03-Dec-09 Influenza Virology Task Groups working meeting
03-Dec-09 First EMA weekly pharmacovigilance report
04-Dec-09 European Medicines Agency advises of risk of fever among young children following pandemic vaccination
04-Dec-09 WHO said it is too early to judge if pandemic has peaked
08-Dec-09 Advisory Forum Meeting
11-Dec-09 Eurovaccine 2009
14-Dec-09 Estonia begins vaccination
15-Dec-09 Workshop on pandemic response in South East Europe in Bucharest
15-Dec-09 Highest number of deaths announced in EU and EFTA countries - 319
16-Dec-09 Health Security Committee Communicators‟ network meeting
16-Dec-09 EMA publishes third weekly pandemic pharmacovigilance report
17-Dec-09 Eight update of ECDC‟s Risk Assessment
17-Dec-09 Advisory Forum teleconference on Forward Look Risk Assessment
18-Dec-09 Health Security Committee influenza section teleconference with the EMA
18-Dec-09 Albania begins vaccination
18-Dec-09 FYROM begins vaccination
18-Dec-09 Iran begins vaccination
18-Dec-09 Montenegro begins vaccination
18-Dec-09 Serbia begins vaccination
18-Dec-09 EMA updates on pandemic medicines
18-Dec-09 Contribution to ECDC Q&A for health professionals on vaccines and vaccination in relation to the 2009 influenza A(H1N1) pandemic
18-Dec-09 ECDC Q&As for the Public on pandemic vaccines were updated
18-Dec-09 ECDC Q&As for Experts on pandemic vaccines were updated
19-Dec-09 Update to the Q & A on vaccines for general public
22-Dec-09 Adoption by the European Council of Recommendation on Seasonal influenza immunisation
23-Dec-09 EMA publishes fourth weekly pandemic pharmacovigilance report
27-Dec-09 Malta begins vaccination
29-Dec-09 Publication of recommendations on seasonal influenza vaccination
14-Jan-10 Annual meeting of the Advisory Board of the EU Project Flusecure
18-Jan-10 Advisory Forum teleconference on Future look Risk Assessment
18-Jan-10 EMA visited ECDC
18-Jan-10 ECDC goes to PHE level 0
19-Jan-10 Publication of last ECDC Daily Update
22-Jan-10 Statement of the World Health Organization on allegations of conflict of interest and 'fake' pandemic
22-Jan-10 EMA recommends update of product information for Tamiflu
22-Jan-10 EMA recommends update of product information for Pandemrix to include more data from studies in children
22-Jan-10 EMA recommends fourth pandemic vaccine for approval
01-Feb-10 Report on Background rates for AESIs was shared with EMA
02-Feb-10 European Commission-led evaluation of the pandemic response at the EU level
09-Feb-10 Planning meeting with Nordic countries on pandemic response evaluation
14-Feb-10 World Health Organization strain selection and vaccine meeting
17-Feb-10 Advisory Forum meeting
18-Feb-10 WHO recommended viruses for influenza vaccine use in the 2010–2011 Northern Hemisphere influenza season
18-Feb-10 Obtained Background rates using common software in national or regional databases from eight countries were discussed and a publication plan was agreed upon
18-Feb-10 Update on SCCS and CCS on-going in participating countries
19-Feb-10 CHMP recommends fifth pandemic vaccine for marketing authorisation
19-Feb-10 Immunogenicity tests for Celvapan – outcome of a meeting of vaccination experts
22-Feb-10 Steering Group meeting for the Belgium EU Presidency
24-Feb-10 Director-General statement following the seventh meeting of the Emergency Committee
03-Mar-10 EU Health Working Party meeting
08-Mar-10 ECDC's Forward look risk assessment for the 2009 pandemic influenza A(H1N1) and future influenza season
19-Mar-10 EMA recommends update of product information for Celvapan to include data from clinical studies
23-Apr-10 Contribution to 'Support tool for EU Member States' internal review of pandemic vaccination strategy' and to 'EU strategic questions on pandemic vaccination strategies'
23-Apr-10 Marketing authorisations for Celvapan, Focetria and Pandemrix recommended to be switched to 'full'
30-Apr-10 ECDC ceases searching for announced deaths
01-Jun-10 Meeting of the European Influenza Surveillance Network in Sofia June 1-4th
01-Jun-10 Annual Meeting of the European Influenza Surveillance Network (EISN)
07-Jun-10 Face to Face Meeting of the EU Vaccine Task Force in Brussels
23-Jun-10 Proof of concept for data linkage studies, known association investigated MMR and TP in two participating countries
23-Jun-10 First preliminary data shared from SCCS and CCS for GBS and pandemic vaccines – study will continue until October 31, 2010
23-Jun-10 External participants in meeting: EMA Jim Slattery, WHO HQ Patrick Zuber
24-Jun-10 Validation procedures for obtained background rates was agreed
24-Jun-10 External Steering Committee meeting - An overview of results from VAESCO project were presented and Advice on the future of VAESCO was provided
01-Jul-10 EU Belgian Presidency Conference on the Lessons Learnt from the Pandemic - Brussels
05-Jul-10 Informal Health Council under the Belgian EU Presidency debates the lessons learnt from the pandemic
10-Jul-10 Ninth meeting of the WHO Pandemic 2009 Emergency Committee – Recommends World no longer in pandemic
10-Jul-10 WHO Director General announces that the world is no longer in a pandemic